Cargando…
Expression signature, prognosis value, and immune characteristics of Siglec-15 identified by pan-cancer analysis
Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) is considered a novel anti-tumor target comparable to programmed cell death 1 ligand 1(PD-L1). However, little is known about Siglec-15. Our study aims to understand its expression signature, prognosis value, immune infiltration pattern,...
Autores principales: | Li, Baihui, Zhang, Bailu, Wang, Xuezhou, Zeng, Ziqing, Huang, Ziqi, Zhang, Lin, Wei, Feng, Ren, Xiubao, Yang, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480813/ https://www.ncbi.nlm.nih.gov/pubmed/32939323 http://dx.doi.org/10.1080/2162402X.2020.1807291 |
Ejemplares similares
-
Non-spatial and spatial heterogeneity revealed a suppressive immune feature of Siglec-15 in lung adenocarcinomas
por: Li, Baihui, et al.
Publicado: (2023) -
TOP2A Promotes Lung Adenocarcinoma Cells' Malignant Progression and Predicts Poor Prognosis in Lung Adenocarcinoma
por: Kou, Fan, et al.
Publicado: (2020) -
Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy
por: Kou, Fan, et al.
Publicado: (2022) -
Immunosuppressive checkpoint Siglec-15: a vital new piece of the cancer immunotherapy jigsaw puzzle
por: Ren, Xiubao
Publicado: (2019) -
A pan‐cancer blueprint of genomics alterations and transcriptional regulation of Siglecs, and implications in prognosis and immunotherapy responsiveness
por: Mei, Song, et al.
Publicado: (2023)